If approved, imlifidase will be the first treatment to address highly sensitized patients awaiting kidney transplantation. LUND, Sweden, ...

If approved, imlifidase will be the first treatment to address highly sensitized patients awaiting kidney transplantation. LUND, Sweden, March 4, 2026 /PRNewswire/ -- Hansa Biopharma ...

Researchers discovered that the mitochondrial MIM complex influences lipid droplet accumulation in yeast cells through ...

Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...

Researchers discovered that coronaviruses exploit cellular stress responses to activate enzymes that modify transfer RNAs, reshaping the protein-making machinery to favor viral replication.

The tissue grafts have the potential to help thousands of Americans on transplant waitlists—amid a shortage of donor livers.

High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease ...

Over thousands of years of domestication, humans have moulded fruit to their liking. Today’s peaches are 16 times the size of their ancient ancestors. The 1,200 varieties of watermelon bear little ...

Under the terms of the agreement, Codexis will produce siRNA material to support its partner's preclinical program. The engagement represents an important demonstration of the platform's ability to ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Epoch Biodesign has joined T2T Alliance to support policy and regulatory frameworks to scale textile-to-textile recycling ...